維百奧現(xiàn)貨銷售Svar Lifescience現(xiàn)貨試劑盒
| 產(chǎn)品信息
品名：Svar Lifescience現(xiàn)貨試劑盒
品牌：Lifecore
| 產(chǎn)品系列
1）WIESLAB? Complement Alternative Pathway (RUO)
貨號：COMPLAP330RUO
The Wieslab? Complement System Alternative Pathway kit is an enzyme immunoassay for the qualitative determination of functional alternative complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab??Complement System Alternative pathway.
The Wieslab Complement assay combines tthe specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. The amount of C5b-9 generated is proportional to the functional activity of the complement system. The convenient ELISA technology has several advantages compared to the traditional hemolytic assays.
2）WIESLAB? Complement MBL Pathway (RUO)
貨號：COMPLMP320RUO
The Wieslab? Complement System MBL pathway kit is an enzyme immunoassay for the qualitative determination of MBL complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab Complement System MBL Pathway.
The assay combines the specific activation of each pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as a result of complement activation. The amount of C5b-9 generated is proportional to the functional activity of complement pathways.
3）WIESLAB? Complement Classical Pathway (RUO)
貨號：COMPLCP310RUO
The Wieslab? Complement System Classical Pathway is an enzyme immunoassay for the qualitative and/or semi-quantitative determination of functional classical complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab? Complement System Classical Pathway.
The?Wieslab Complement System Classical Pathway assay combines the specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. The amount of complement activation can be expressed either in a qualitative way relative the value of a positive control or in a semi-quantitative way using a calibrator curve derived from a separate lyophilized activity control.
關(guān)鍵字： COMPLAP330RUO;COMPLMP320RUO;COMPLCP310RUO;Svar試劑盒;
維百奧（北京）生物科技有限公司成立于2014年，經(jīng)營范圍包括: 技術(shù)服務(wù)、技術(shù)開發(fā)、技術(shù)咨詢、技術(shù)交流、技術(shù)轉(zhuǎn)讓、技術(shù)推廣;儀器儀表制造;儀器儀表銷售;儀器儀表修理;化工產(chǎn)品生產(chǎn)(不含許可類化工產(chǎn)品);化工產(chǎn)品銷售(不含許可類化工產(chǎn)品);專用化學(xué)產(chǎn)品制造(不含危險化學(xué)品);專用化學(xué)產(chǎn)品銷售(不含危險化學(xué)品);計算機系統(tǒng)服務(wù);數(shù)據(jù)處理和存儲支持服務(wù);軟件開發(fā);工程技術(shù)服務(wù)(規(guī)劃管理、勘察、設(shè)計、監(jiān)理除外);新材料技術(shù)推廣服務(wù);進出口代理;貨物進出口;技術(shù)進出口。(除依法須經(jīng)批準的項目外，憑營業(yè)執(zhí)照依法自主開展經(jīng)營活動)(不得從事國家和本市產(chǎn)業(yè)政策禁止和限制類項目的經(jīng)營活動。)